European regulators reportedly have given Japanese firm Cyberdyne the green light to start clinical studies of its HAL robotic exoskeleton. The battery-operated device is intended to help patients in rehab facilities who have suffered stroke or other debilitating conditions by assisting them with activities such as walking and climbing stairs.
Cyberdyne gets CE mark for study of robotic exoskeleton
SmartBrief Job Listings for Health Care
|Compliance and Ethics Director||
Sysmex America, Inc.
|Director, Site Quality Management||
|Palm Springs, CA|
|Compliance Officer-Medical Products||
W. L. Gore